Ive known Brent Rutemiller CEO of Swimming World and the International Swimming Hall of Fame for about 20 years, our relationship first developed through business. But when you work closely with someone, there is a great opportunity to develop a friendship and Im glad that I get to call Brent a good friend. So, when he reached out almost a year ago with the news that he was diagnosed with plasma-cell leukemia, it was a tough conversation to say the least.
Yet, something from our early chats stood out. Brent didnt have this woe-is-me mentality. Truthfully, he didnt have time for that attitude, nor did he care to mope. No, Brent was going to beat this thing. How? Those details would come later, and as you will see in his letter below, his fight was not without several pitfalls, moments of doubt and frustration. Through it all, though, Brent remained positive, refused to dwell on any setbacks and was steadfast in the fact that one day he was going to receive excellent news and could be used as motivation for others battling a cancer diagnosis.
Today, Swimming World is thrilled to announce that Brent is in early remission from the cancer which wracked his body. Its an achievement to celebrate, and as I told Brent last week, this wonderful news is his moment atop the podium. He claimed victory. He beat the opposition. He captured gold.
The following letter is Brent Rutemillers detailed announcement of the early-remission news delivered by his doctor regarding his fight against cancer.
I finally got my long-awaited blood test results to see if my stem cell transplant was successful.
It will soon be one year since I was diagnosed with cancer. 90% of my plasma was filled with cancer and my kidneys were failing over Memorial Day Weekend last year. Dr. Google said I had 5 months to live. The first 48 hours, I felt sorry for myself. Then I decided that feeling sorry was a useless emotion. I was going to either win or die, there was no second place. I made the decision that the only thing I can control was my attitude and exercise.
I began walking circles in my hospital room and then progressed to the hospital floor. They put a port in my chest and started giving me chemo three times a week. They flooded me with pills to the point that on some days I was taking over 20 within a 24-hour period. They pounded me with steroids once a week to where I now have cataracts in both eyes and will need surgery.
Photo Courtesy:
With the help of Rob Butcher, I was able to get Dr. Fonseca, head of the Mayo Oncology Department to take me as his patient, but first Mayo had to accept me into their system. With the constant loving support of my wife, Ellen Rutemiller, she navigated the insurance paperwork and maze of hoops to get me admitted into Mayo. I cant tell you the number of times they said, no! to her. She then had to navigate Medicare and our secondary insurance policies while being on hold for hours to get our expenses down considerably. She learned the system and got me the best care and insurance coverage possible. Ellen never gave up fighting for me and never took no for an answer.
For 42 straight weeks, they lit me up with chemo causing night sweats, dizzy spells, loss of appetite, reduced oxygen in my blood and days of no energy. All the time, I tried to walk, hike or swim to push those poisons out of my body and keep moving. I only missed about 20 days of working remotely while leading the International Swimming Hall of Fame through Covid, Induction cancellations, closures, and construction disruptions.
Every week Mayo would draw blood to measure my cells and cancer. There were days when my hemoglobin was so low that I needed transfusions.
Over the holidays, I had a reaction to one of my drugs after developing a full-body skin rash. They took me off that drug and my cancer increased.
Then I got Covid! They stopped Chemo for two weeks and gave me a monoclonal covid shot to help me through the virus. After I recovered, the blood tests showed that the cancer was increasing.
I was discouraged as they decided to get more aggressive in February.
They put me back in the hospital and inlaid a three-port line into my chest that tunneled directly into my heart. They wasted no time and infused me through my new ports with 4 different chemotherapies at one time. They let the medicines drip into my veins for 72 straight hours. Then they started giving me another chemo shot in the stomach.
Chemo Blast
Somehow, I found the strength to get out of bed and walk in circles again. Somedays, I got up to 3 miles with Ivan beside me. (Ivan was the name of the IV pole that I pushed around.)
Rutemillers Army Pin
Every nurse along the way got a Rutemillers Army pin as I told them that I was going to be The first person cured of this dreaded cancer. Some of them said they believed me.
After they discharged me, I lost all my hair, but the Chemo Blast treatment was working. The cancer was receding quickly in my blood, but not fast enough.
We were quickly running out of time, so they decided to proceed with harvesting my stem cells to replace the cancer cells in my marrow. My body cooperated by delivering 11.5 million stem cells over two days of harvesting.
The time came on March 16th, to start the stem cell transplant. They hit me with the highest dose of Chemo to wipe out all my marrow producing cells.
Two days later, on March 18th, they infused me with 5.25 million of my own stem cells to take me back to my factory settings and froze the remaining cells. The treatment wiped out all my childhood vaccinations and any other ones in my life. I had no immune system and had to be isolated at home for 30 days as my marrow regenerated.
After 7 days, I unexpectedly vomited after lunch and then developed a fever. Mayo called in the Infectious Disease Team and identified five different bacteria in my blood. The wired me up to a broad-spectrum of antibiotics that wrecked my gut. I stayed in the hospital for five more days.
My red blood and plasma dropped to a critical point forcing two infusions of each. I went home in pain and finally succumbed to a pain killer for the first time, but for only two days.
10 days later the entire family caught norovirus. It took us all four days to recover from severe Gastrointestinal issues.
Since then, I have been getting stronger. Last week marked the 50th day since my transplant. I am back to pre-cancer exercise having swum 3000 yards this morning and hiking in the mountains on Tuesdays and Thursdays with Glenn Mills my Olympic standard.
The Mayo Doctors usually wait 100 days before testing, but because my cancer is so aggressive, they tested me on day fifty.
I was not expecting good news when I got a text from the doctor saying that they COULD NOT FIND ANY CANCER in my blood It is in the normal range!!! (Note he added three exclamation points.). So, after almost one year of positive prayers from everyone, and positive attitudes cheering me on, and regular exercise, I can say that my cancer is in EARLY REMISSION. We did it!!!
We now have the upper hand. Remission for my cancer can last 2-4 years, or longer. The way I see it, with the support of my lovely wife, and with the expertise of Mayo, guidance from my god (who surely got a few words from my mom who passed away 4 days ago), and the support of Rutemillers Army we will reach the goal of FINDING a cure
Brent Rutemiller CEO, President of International Swimming Hall of Fame
- Hannah just thought she was being clumsy, but her bruises were a sign she needed to see her doctor - Daily Mail - October 27th, 2023
- Other Notable Health Studies & Research From May 17, 2022 - Study Finds - May 20th, 2022
- Clinton County Relay For Life holds annual event in Riverview Park - Lock Haven Express - May 20th, 2022
- Illinois Is Being Invaded By Worms That Jump A Foot In The Air - 1440wrok.com - May 20th, 2022
- Moderna, J&J COVID Booster Shots Near Authorization. Here's What to Know - NBC Chicago - October 26th, 2021
- GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF- R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research -... - October 26th, 2021
- Merck Provides Update on KEYTRUDA (pembrolizumab) Indication in Third-Line Gastric Cancer in the US - Business Wire - July 6th, 2021
- Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene - GlobeNewswire - July 6th, 2021
- New global guidelines for stem cell research aim to drive discussions, not lay down the law - The Conversation AU - May 27th, 2021
- Merck (MRK) Granted Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) in Combination with Chemotherapy - StreetInsider.com - May 27th, 2021
- Merck Receives Positive EU CHMP Opinion for KEYTRUDA in Combination With Chemotherapy as First-Line Treatment for Certain Patients With Esophageal... - May 27th, 2021
- Epigenetic therapies for heart failure | VHRM - Dove Medical Press - May 27th, 2021
- OPDIVO (nivolumab) in Combination with CABOMETYX (cabozantinib) Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for... - February 14th, 2021
- AlloVir Research Presented at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Business Wire - February 14th, 2021
- Opdivo in Combination with Cabometyx Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced RCC -... - February 14th, 2021
- Astellas and Seagen Announce Presentation of Results from PADCEV (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced... - February 14th, 2021
- [Full text] Loganin Attenuates Septic Acute Renal Injury with the Participation of | DDDT - Dove Medical Press - February 14th, 2021
- [Full text] Encephalopathy Induced by Preventive Administration of Acyclovir in a | IJGM - Dove Medical Press - February 14th, 2021
- Joint inflammation: Causes, treatment, and symptoms - Medical News Today - February 14th, 2021
- Creative Medical Technology Holdings Identifies and Files Patent on Novel Mechanism of ImmCelz Therapeutic Activity - PRNewswire - February 3rd, 2021
- How Coronavirus Damages Lung Cells Within Mere Hours And What Drugs Could Halt COVID-19 Infection - SciTechDaily - February 3rd, 2021
- Mini kidneys bioprinted in the lab - Lab + Life Scientist - December 4th, 2020
- Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine - BioSpace - December 4th, 2020
- News briefing: Four biotechs announce IPO terms, setting the pace to round out a busy year; FDA sets PDUFA date for Kadmon's graft-versus-host drug -... - December 4th, 2020
- Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - Philippine Canadian... - December 4th, 2020
- Merck Announces KEYNOTE-598 Trial Evaluating KEYTRUDA in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain Patients With Metastatic... - November 11th, 2020
- KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Demonstrated Statistically Significant Improvement in Progression-Free Survival (PFS), Overall... - November 11th, 2020
- Gilead and Kite to Share Latest Scientific Advances in Hematologic Malignancies at ASH 2020 - Investing News Network - November 11th, 2020
- The great reset: new danger on the horizon - Amandala - November 11th, 2020
- Teladoc Is A Strong Buy: A Radical Healthcare Change Will Come - Seeking Alpha - November 11th, 2020
- COVID Drug Given to Trump Developed From Aborted Fetus Cells - Quint Fit - October 10th, 2020
- Lars Jaeger: The Future is Veggie, With 3D Printing - finews.asia - October 10th, 2020
- Laid off from ImmunoGen, an ex-Genzyme and Shire exec heads to an ARCH upstart - Endpoints News - October 10th, 2020
- 5 Deadly Pre-existing Conditions You Could Have Due To COVID-19 - Brumpost - Brumpost - October 10th, 2020
- The Crypto Daily Movers and Shakers October 10th, 2020 - Sports Grind Entertainment - October 10th, 2020
- Coronavirus Tracker: Bexar Co. cases surpass 59,000; Texas hospitalizations trending in the wrong direction - KENS5.com - October 10th, 2020
- Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million - Business Wire - September 24th, 2020
- Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations - BioSpace - September 15th, 2020
- Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL Amyloidosis - Business Wire - September 15th, 2020
- Braunstein Reflects on the Rise of Quadruplet Therapies in Multiple Myeloma - OncLive - September 9th, 2020
- Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients - GlobeNewswire - September 9th, 2020
- ASX Biotechs Surfing The Covid Story - FN Arena News - August 16th, 2020
- Merck and Eisai Receive Complete Response Letter for KEYTRUDA (pembrolizumab) plus LENVIMA (lenvatinib) Combination as First-Line Treatment for... - July 10th, 2020
- FDA Approves Talaris Therapeutics' IND for Its Allogeneic Cell Therapy FCR001 to Be Evaluated in Patients With a Severe Form of Scleroderma - Business... - July 10th, 2020
- Coronavirus PPP Loans In Livingston: Where The Money Went - Livingston, NJ Patch - July 9th, 2020
- Stem Cell Therapy For Kidney Failure. Learn More Now ... - July 7th, 2020
- Anemia in chronic kidney disease - kidneyfund.org - July 7th, 2020
- Dr Borehams Crucible: Mesoblast within months of 3 major trial results, key regulatory decision - Stockhead - July 7th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer -... - June 30th, 2020
- R3 International Offering Stem Cell Therapy Program for Anti Aging in Mexico - PR Web - June 30th, 2020
- Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter - Stockhouse - June 30th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that... - June 25th, 2020
- Simcha Therapeutics Launches to Engineer Therapeutic Cytokines to Unlock the Full Potential of the Immune System - Business Wire - June 25th, 2020
- First American to Receive Placental Cell Treatment For COVID-19 is an Acclaimed Broadway Scenic Designer - Science Times - May 27th, 2020
- Scientists generate millions of mature human cells, far more than have ever been produced - UB News Center - May 20th, 2020
- Heres The Reason Why Scientists Are Growing Human Cells In Mouse Embryo - Medical Daily - May 20th, 2020
- Cell therapies trial planned for COVID-19 - Mirage News - May 5th, 2020
- New Study Finds That Wearing Contact Lenses Doesn't Increase Risk of COVID-19 Infection - HealthDay Coronavirus Liveblog - April 26th, 2020
- Israeli COVID-19 treatment with 100% survival rate tested on US patient - The Jerusalem Post - April 15th, 2020
- Stem Cells and Chronic Kidney Disease | Mayo Clinic Center ... - April 11th, 2020
- Kidney Failure | Stem Cell Treatment in Tijuana Mexico - April 11th, 2020
- MESOBLAST PARTNERS WITH THE CARDIOTHORACIC SURGICAL TRIALS NETWORK ESTABLISHED BY THE U.S. NATIONAL INSTITUTES OF HEALTHS NATIONAL HEART, LUNG AND... - April 11th, 2020
- Merck Receives Priority Review from FDA for Second Application for KEYTRUDA (pembrolizumab) Based on Biomarker, Regardless of Tumor Type - Benzinga - April 11th, 2020
- A coronavirus vaccine is being developed in record time. But dont expect that technology to speed up flu vaccines yet. - Columbia Daily Herald - April 7th, 2020
- Researchers test drug that stops early stages of COVID-19 - Open Access Government - April 7th, 2020
- Can cell-based therapy be helpful in tackling coronavirus? - YourStory - March 25th, 2020
- Made-in-space organs could soon be reality - ETHealthworld.com - March 13th, 2020
- What Is the Coronavirus? - WIRED - March 6th, 2020
- 34 years with a new heart and counting - MDJOnline.com - February 25th, 2020
- Coronavirus: Doctors try 3,000-year-old Traditional Chinese Medicine (TCM) to treat the virus - Times of India - February 20th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for... - February 14th, 2020
- Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV (enfortumab vedotin-ejfv) in Combination with Immune Therapy... - February 14th, 2020
- Omeros: 2 Major Catalysts On The Horizon - Seeking Alpha - February 10th, 2020
- Cambridge Science Festival showcases new research at the forefront of healthcare and medicine - Cambridge Network - February 10th, 2020
- Anemia: Causes, symptoms and treatment - Livescience.com - February 8th, 2020
- 4 Crazy but Effective Ways to Save More Money This Year - Nasdaq - February 4th, 2020
- BAME lives to be saved as new organ donation law rolls out - Keep the Faith - January 15th, 2020
- HIV drug resistance an emerging threat, expert warns - DAWN.com - January 10th, 2020
- A Lasting Legacy: DuPont, C8 Contamination and the Community Left to Grapple With the Consequences - alleghenyfront.org - January 10th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Significantly Improved Progression-Free Survival Compared to Chemotherapy Alone as... - January 6th, 2020